Stay updated on Nivolumab vs Investigator's Choice in Head and Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab vs Investigator's Choice in Head and Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab vs Investigator's Choice in Head and Neck Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    No Change Detected
  4. Check
    3 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T22:30:30.000Z thumbnail image
  5. Check
    4 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the study record related to a clinical trial comparing Nivolumab to therapy of investigator's choice in patients with recurrent or metastatic head and neck carcinoma.
    Difference
    0.1%
    Check dated 2024-06-06T14:31:49.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The webpage section previously displaying the last update dates has been updated to provide detailed information about the participation and eligibility criteria for the clinical trial, including general health conditions and prior treatments required for participants.
    Difference
    16%
    Check dated 2024-05-22T20:54:01.000Z thumbnail image
  8. Check
    47 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:36:56.000Z thumbnail image

Stay in the know with updates to Nivolumab vs Investigator's Choice in Head and Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Investigator's Choice in Head and Neck Cancer Clinical Trial page.